- Administration of isothiocyanate (E-4IB) and cisplatin leads to alter…
Number of the records: 1  

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells

  1. DURAJ, J. et al. Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2009, 2009, vol. 56, no. 3, s. 208-214.
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.